Equities

Touchstone International Medical Science Co Ltd

688013:SHH

Touchstone International Medical Science Co Ltd

Actions
Health CareMedical Equipment and Services
  • Price (CNY)18.81
  • Today's Change-0.23 / -1.21%
  • Shares traded987.71k
  • 1 Year change-17.28%
  • Beta--
Data delayed at least 15 minutes, as of Nov 15 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in CNYIncome statement in CNYView more

Year on year Touchstone International Medical Science Co Ltd grew revenues 9.31% from 232.03m to 253.65m while net income improved 9.53% from 43.20m to 47.31m.
Gross margin55.96%
Net profit margin20.78%
Operating margin20.83%
Return on assets9.05%
Return on equity10.13%
Return on investment10.06%
More ▼

Cash flow in CNYView more

In 2023, Touchstone International Medical Science Co Ltd increased its cash reserves by 540.00%, or 178.48m. Cash Flow from Investing totalled 97.97m, indicating this company earned more from the sale of existing assets than it spent on the purchase of new assets. In addition the company generated 82.95m in cash from operations while cash used for financing totalled 4.74m.
Cash flow per share--
Price/Cash flow per share--
Book value per share7.05
Tangible book value per share6.55
More ▼

Balance sheet in CNYView more

Touchstone International Medical Science Co Ltd has a strong Balance Sheet and has consistently grown its cash reserves over the last Four years to total 211.53m.
Current ratio5.19
Quick ratio4.76
Total debt/total equity0.0028
Total debt/total capital0.0028
More ▼

Growth rates in CNY

Year on year, growth in dividends per share fell -100.00% while earnings per share excluding extraordinary items rose 14.37%. Additionally, five year annualized earnings per share growth is in-line with the industry average relative to its peers.
EPS growth(5 years)15.96
EPS (TTM) vs
TTM 1 year ago
27.51
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.